Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The renal or extrarenal expression of 1--hydroxylase (CYP27B1) enzymatic action converts 25(OH)VD 3 to an active metabolite 1,25-dihydroxy vitamin D 3 (1,25(OH) 2 VD 3) 13
Titration and adjustment: During treatment, the template becomes instrumental for healthcare providers to titrate the dosage as needed
AOD-9604 typically comes in 2mg or 5mg vials
Of these receptor subtypes, Y1R and Y2R are particularly involved in modulating bone mass, but they do so through different mechanisms and at different sites
In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02
